Coya Therapeutics Profit Margin

Coya Therapeutics (COYA) currently reports a profit margin of -230.44% as of March 2026. That compares with -465.0% in the prior-year period — up 50.4% year over year. That is below the sector sector average of 19.61%. Use the charts on this page to explore Coya Therapeutics's profit margin history and peer comparisons.

Coya Therapeutics's profit margin increased from -465.0% to -230.44% — a 50.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Coya Therapeutics's profit margin of -230.44% is lower than the its sector sector average of 19.61%. That is roughly 1275.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Coya Therapeutics's current -230.44% should be judged against industry norms (sector average: 19.61%) and against COYA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -230.44%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 19.61%. From there, open related valuation or income-statement pages for Coya Therapeutics, and consider following COYA for alerts when major investors trade the stock.